The Cardiac Exchange Podcast

Left atrial appendage management

Listen as Prof. Pieter Kappetein discusses left atrial appendage management with Dr. Kelley Hutcheson of Baylor, Scott and White, Dr. Jeffrey Miller of Emory University School of Medicine, Dr. Basel Ramlawi of Lankenau Heart Institute, and Dr. Gregory Rushing of University Hospitals.

SAVR vs. TAVR: lifetime management for patients

Cardiac surgeons Dr. Michael Reardon from Houston Methodist and Dr. Bradley Leshnower from Emory University with interventional cardiologist Dr. Sachin Goel from Houston Methodist discuss SAVR versus TAVR. Topics include: which patients benefit from SAVR procedures, considerations for optimizing SAVR via root enlargement, and lifetime patient management as it relates to SAVR versus TAVR procedures.

Recent happenings and trends in mitral valve repair

In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients.

Learn more about the importance of MICS procedures, critical steps to set up a robotics program, and the importance of the mitral heart team.

Lifetime management of surgical aortic valve replacement patients

There are many options for the treatment for aortic valve disease. Tune in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Joseph Bavaria from the Hospital of the University of Pennsylvania, Dr. Bob Kiaii from UC Davis Medical Center, and Dr. Maral Ouzounian from the Toronto General Hospital as they discuss the lifetime management of surgical aortic valve replacement patients.

Anticoagulation after bioprosthetic aortic valve replacement

Listen as Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, speaks with Dr. Juan Crestanello of Mayo Clinic in Rochester, MN, Dr. Mark Cunningham of Brigham and Women’s Hospital in Boston, MA, and Dr. Katherine Harrington of Baylor, Scott, and White in Plano, TX, about anticoagulation after bioprosthetic aortic valve replacement. Topics include: anticoagulation guideline compliance, medication options, strategies based on patient age, and thoughts on future practices.

The evolution of ECMO with Dr. Robert Bartlett

Lifesaving ECMO therapy continues to evolve. Tune in to this one-on-one interview, where Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, talks with world-renowned surgeon and heralded "father of ECMO," Dr. Robert Bartlett. They discuss the evolution of ECMO since its inception and the key trends and guidelines driving lifesaving ECMO changes today. Dr. Bartlett also shares his perspective on the key success factors for those interested in starting an ECMO program.

Current practices and future state of coronary surgery

Hear an in-depth discussion on the current and future state of coronary surgery. This series is led by Professor Pieter Kappetein, who is joined by Dr. Marc Ruel of the Ottawa Heart Institute, Dr. John Puskas from Mount Sinai Morningside in New York, and Dr. Teresa Kieser from the University of Calgary. Together, they will provide insights into the progress, current trends, and the future of coronary surgery — covering topics that include the role of total arterial revascularization, minimally invasive approaches, and learning outside of the fellowship.

2022 STS highlights

Don’t miss the discussions where Dr. Gene Grossi from NYU talks with experts regarding the 2022 STS annual meeting. Our expert panel includes Dr. Jessica Forcillo from the University of Montreal, Dr. Shinichi Fukuhara from the University of Michigan, Dr. Jessica Luc from the University of British Columbia, and Dr. Tom Nguyen from UCSF.

2022 ACC/AHA coronary revascularization guidelines

A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with three-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG versus medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.

2021 EACTS highlights

Listen in to hear Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Professor Bart Meuris of UZ Leuven in Belgium, and Professor Martin Andreas of the Medical University of Vienna discuss highlights from the 2021 EACTS annual conference.

The next generation

Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, sits down with four cardiac surgery residents and fellows for a candid chat. James Bailey, M.D., Tessa Watt, M.D., Daniel Ziazadeh, M.D., and Natalie Ostro, M.D. talk about their start in cardiac surgery, current challenges, workplace dynamics, and the future of the of the specialty.

Diversity in healthcare

Listen to Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Kendra Grubb of Emory University, Dr. Vivek Rao of Toronto General, and Dr. J.W. Awori Hayanga of West Virginia University discuss the importance of diversity in healthcare.

Hear what their institutions are doing to achieve it and the challenges they are overcoming along the way.

COVID and cardiac surgery — where are we now?